The way I looked it is how many spec Aussie biotechs actually make commercialisation, still with only 190m SOI, and circa $4 m cash in the bank?
ANd how many have the range of markets, the disruptive products and therefore the growth profile.
Looking at today's volume, the market really hasn't caught on to this one yet. When it goes, and the shorts need to cover, we will get out 2m share + turnover days, remove stale investors and start to see its real value.
Milesy
The way I looked it is how many spec Aussie biotechs actually...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.015(3.90%) |
Mkt cap ! $60.50M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 37.0¢ | $457.2K | 1.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 49050 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 19500 | 1 |
View Market Depth
| Last trade - 15.39pm 13/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |